PMID- 31303625
OWN - NLM
STAT- MEDLINE
DCOM- 20190718
LR  - 20190718
IS  - 1672-7347 (Print)
IS  - 1672-7347 (Linking)
VI  - 44
IP  - 5
DP  - 2019 May 28
TI  - [A case of nephrectomy with strong positive HLA antibody undergoing the third 
      renal transplantation].
PG  - 596-599
LID - 10.11817/j.issn.1672-7347.2019.05.018 [doi]
AB  - The positive human leukocyte antigen (HLA) antibody present in kidney transplant 
      recipients affects both surgery and rejection, and also affects the long-term 
      survival of the transplanted kidney. During the third kidney transplant, 
      bilateral axillary fossa and iliac vessel were destroyed. It was very difficult 
      for selection or separation of surgical vessels because the adhesions and scar 
      formation was easy to damage blood vessels and intestinal tubes. A case with 
      strong positive HLA antibody undergoing the third kidney transplant in our 
      hospital was successfully solved the problems, such as less transplant space and 
      vascular scar adhesion. Rituximab, rabbit anti-human thymocyte immunoglobulin, 
      and methylprednisolone treated-antibodies were used in the operation. The immune 
      function test was used to develop individualized treatment after the operation. 
      The postoperative creatinine and urine volume tended to be stable, and the 
      16-month follow-up renal function was good.
FAU - Deng, Pan
AU  - Deng P
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
FAU - Zhang, Sheng
AU  - Zhang S
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
FAU - Ming, Yingzi
AU  - Ming Y
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
FAU - Cheng, Ke
AU  - Cheng K
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
FAU - Wang, Qiang
AU  - Wang Q
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
FAU - Ye, Qifa
AU  - Ye Q
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
FAU - Zhao, Yujun
AU  - Zhao Y
AD  - Organ Transplantation Center, Third Xiangya Hospital, Central South University, 
      Changsha 410013, China.
LA  - chi
PT  - Case Reports
PT  - Journal Article
PL  - China
TA  - Zhong Nan Da Xue Xue Bao Yi Xue Ban
JT  - Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. 
      Medical sciences
JID - 101230586
RN  - 0 (Antibodies)
RN  - 4F4X42SYQ6 (Rituximab)
SB  - IM
MH  - Antibodies
MH  - Humans
MH  - Kidney
MH  - Kidney Diseases/*surgery
MH  - *Kidney Transplantation
MH  - Nephrectomy
MH  - Rituximab
EDAT- 2019/07/16 06:00
MHDA- 2019/07/19 06:00
CRDT- 2019/07/16 06:00
PHST- 2019/07/16 06:00 [entrez]
PHST- 2019/07/16 06:00 [pubmed]
PHST- 2019/07/19 06:00 [medline]
AID - 10.11817/j.issn.1672-7347.2019.05.018 [doi]
PST - ppublish
SO  - Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 May 28;44(5):596-599. doi: 
      10.11817/j.issn.1672-7347.2019.05.018.